New Technology Gives GE Healthcare (NASDAQ:GEHC) a Boost

GE Healthcare, a medical technology company listed on NASDAQ:GEHC, has proven that it can stand on its own despite initial concerns about its ability to do so without the support of the broader GE brand. The company’s new technology, including the Prostate Volume Assist (PVA) system and the Ionic Health nCommand Lite system, shows promise in the healthcare industry.

The PVA system uses artificial intelligence (AI) to accurately measure the volume of a human prostate, which is essential for determining whether a prostate is cancerous or not and can also be beneficial in treating other neurological disorders. The PVA system is included with several GE Healthcare ultrasound systems and produces quick and reliable results that make diagnoses easier for physicians.

GE Healthcare recently announced the distribution of the Ionic Health nCommand Lite system, which has received FDA approval. This system is designed to help alleviate staffing shortages in radiology departments by allowing users to perform patient scanning functions remotely and review images in real-time. This provides a valuable resource for healthcare providers.

On Wall Street, analysts have a Moderate Buy consensus rating on GEHC stock, with seven Buys and three Holds assigned in the past three months. Despite a 17.26% increase in its share price over the past year, the average GEHC price target of $92.22 per share suggests a 2.41% upside potential. Overall, GE Healthcare is showing promise with its innovative technology and strategic partnerships in the healthcare industry.

By Samantha Johnson

As a content writer at, I craft engaging and informative articles that aim to captivate readers and provide them with valuable insights. With a background in journalism and a passion for storytelling, I thoroughly enjoy delving into diverse topics, conducting research, and producing compelling content that resonates with our audience. From breaking news pieces to in-depth features, I strive to deliver content that is both accurate and engaging, constantly seeking to bring fresh perspectives to our readers. Collaborating with a talented team of editors and journalists, I am committed to maintaining the high standards of journalism upheld by our publication.

Leave a Reply